Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-21 Biller Scott Chief Scientific Officer Option exercise +3,000 $0.47 $1K 3,264
2017-06-21 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −4,292 41,719
2017-06-21 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −3,000 17,875
2017-06-14 Cantley Lewis Clayton Jr. Director Sale −500 $51.09 $26K 89,697
2017-06-14 Cantley Lewis Clayton Jr. Director Sale −500 $51.09 $26K 89,737
2017-06-13 Scadden David Director Grant or award · Stock option (right to buy) +8,000 8,000
2017-06-13 MARAGANORE JOHN Director Grant or award · Stock option (right to buy) +8,000 8,000
2017-06-13 Ho Maykin Director Grant or award · Stock option (right to buy) +8,000 8,000
2017-06-13 Foster-Cheek Kaye I Director Grant or award · Stock option (right to buy) +9,000 9,000
2017-06-13 CLARK IAN T Director Grant or award · Stock option (right to buy) +8,000 8,000
2017-06-13 Clancy Paul J Director Grant or award · Stock option (right to buy) +9,000 9,000
2017-06-13 Cantley Lewis Clayton Jr. Director Sale −500 $50.64 $25K 90,197
2017-06-13 Cantley Lewis Clayton Jr. Director Sale −500 $50.64 $25K 90,237
2017-06-13 Cantley Lewis Clayton Jr. Director Grant or award · Stock option (right to buy) +8,500 8,500
2017-06-07 Schenkein David P Chief Executive Officer Option exercise +1,900 $0.30 $575 1,900
2017-06-07 Schenkein David P Chief Executive Officer Sale −1,900 $50.02 $95K 0
2017-06-07 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −1,900 189,656
2017-06-06 Schenkein David P Chief Executive Officer Option exercise +1,100 $0.30 $333 1,100
2017-06-06 Schenkein David P Chief Executive Officer Sale −1,100 $50.02 $55K 0
2017-06-06 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −1,100 191,556

Page 75 of 80 · 1,590 trades